SurGuide

SurGuide, founded in 2018, is dedicated to revolutionizing cancer surgery outcomes. Its slogan, "SurGuide aims to improve cancer surgery outcomes, using a device to ensure complete tumor removal," captures the company's core mission. The innovative medical devices offered by SurGuide are designed to address the challenges in cancer surgery, where inadequate tumor removal often necessitates additional treatments. Utilizing optical technology, the company's disposable device provides real-time feedback during surgery to confirm complete tumor removal, potentially reducing the need for adjuvant therapies. This not only optimizes patient outcomes but also reduces healthcare costs by minimizing the need for further interventions. SurGuide's promising approach has garnered recognition in the form of a €71.43K grant investment from EASME - EU Executive Agency for SMEs on 01 December 2018. This investment not only underscores the substantial potential of SurGuide's solution but also reflects the confidence of influential entities in the company's vision and capabilities.